Advanced Healthcare Materials-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2020-05-14 ms3212165295344000

3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！

269 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2019-07-13 初衷45728bd7

审稿速度:2.0 | 投稿命中率:25.0
经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中

290 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2022-08-12 ms5000000105805022

请问上传production data 都包括哪些？没有处理的数据

181 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2023-01-30 jeremy7226 来自江苏省

审稿速度:2.0
偏重的研究方向：生物材料
经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。

178 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2022-06-04 王璐璐

投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？

174 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2023-05-24 ms5000000742771461 来自山东省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：纳米材料;抗肿瘤
经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗

187 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2020-02-26 玉水清澈

各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？

295 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2022-08-30 ms7000000605102289

审稿速度:2.0 | 投稿命中率:95.0
经验分享：666

182 0

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2018-06-03 一大摞钱68a51aeb

审稿速度:2.0 | 投稿命中率:50.0
经验分享：21 apr 2018 投稿
24 may 2018 一审结果回来，小修；28号修回
28 may 2018 录用
审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！

397 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=860567, encodeId=461c86056ec6, content=3月22提投稿，4月20号来意见，两位审稿人，一小修一大修，5月8号修回，5月19接收。即时if已超7，感谢编辑jing zhu教授！希望杂志越办越好！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93b35414092, createdName=ms3212165295344000, createdTime=Thu May 14 20:55:15 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573654, encodeId=acac5e36540a, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：Advanced Functional Materials转投Advanced Healthcare Materials，期待能中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=290, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86331703273, createdName=初衷45728bd7, createdTime=Sat Jul 13 22:05:00 CST 2019, time=2019-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1238317, encodeId=deae123831ec8, content=请问上传production data 都包括哪些？没有处理的数据, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=483a8273826, createdName=ms5000000105805022, createdTime=Fri Aug 12 17:46:54 CST 2022, time=2022-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2112069, encodeId=3d0121120696e, content=审稿速度:2.0 偏重的研究方向：生物材料 经验分享：2022-11-24投稿，2023-01-08收到审稿人意见，3个审稿人，都提出来宝贵的已经，目前已经修改完，准备明天发回去。希望能接受。我是一作，投稿后是看不到状态的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=178, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff1c2487532, createdName=jeremy7226, createdTime=Mon Jan 30 01:44:32 CST 2023, time=2023-01-30, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1224474, encodeId=9bc912244e437, content=投稿5天，还是Manuscript Submitted,各位朋友有指点一下啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=892d5528317, createdName=王璐璐, createdTime=Sat Jun 04 21:59:09 CST 2022, time=2022-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138826, encodeId=63f82138826c1, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：纳米材料;抗肿瘤 经验分享：投稿14天还是显示Manuscript Submitted，投的是ADV HEALTHC MATER关于纳米材料的综述，正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21228290711, createdName=ms5000000742771461, createdTime=Wed May 24 15:19:03 CST 2023, time=2023-05-24, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=585390, encodeId=2d5b58539018, content=各位大牛，投稿10天一直Under consideration，是送审了吗，一审周期大约多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=295, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a49f5240036, createdName=玉水清澈, createdTime=Wed Feb 26 00:00:00 CST 2020, time=2020-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1242099, encodeId=fb6812420998a, content=审稿速度:2.0 | 投稿命中率:95.0 经验分享：666, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f3338272527, createdName=ms7000000605102289, createdTime=Tue Aug 30 17:48:01 CST 2022, time=2022-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=557531, encodeId=548155e53111, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：21 apr 2018 投稿 24 may 2018 一审结果回来，小修；28号修回 28 may 2018 录用 审稿速度还可以，审稿人和编辑都很nice，很好的杂志。希望分数越来越高！！！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=397, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ca21735535, createdName=一大摞钱68a51aeb, createdTime=Sun Jun 03 19:04:00 CST 2018, time=2018-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1228007, encodeId=a17e122800ea6, content=偏重的研究方向：生物材料 经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa695688096, createdName=ms4000000894908741, createdTime=Wed Jun 22 15:16:32 CST 2022, time=2022-06-22, status=1, ipAttribution=)]

2022-06-22 ms4000000894908741

偏重的研究方向：生物材料
经验分享：请问修回后为什么一直看不到稿件状态啊，已经两天了，求解🙏🙏

184 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务